Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-09-013318
Filing Date
2009-03-11
Accepted
2009-03-11 17:30:52
Documents
1
Period of Report
2009-03-11

Document Format Files

Seq Description Document Type Size
1 v142534_6k.htm 6-K 20144
  Complete submission text file 0001144204-09-013318.txt   21536
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 09673458
SIC: 2834 Pharmaceutical Preparations